VALD Secures Major Investment to Fuel Future Growth
VALD, a prominent health technology company specializing in musculoskeletal (MSK) health, has successfully secured a significant growth equity investment from FTV Capital, which is recognized for its focus on the healthcare and technology sectors. This strategic funding is set to bolster VALD's ability to expand its global footprint, enhance its team, and innovate within its product range specifically designed for the MSK market.
Exploring the MSK Market and VALD's Contribution
The MSK health market is extensive yet largely under-addressed, with healthcare budgets dedicating a significant share to MSK services. In the U.S., this represents nearly 12% of all healthcare spending. Traditional MSK care often suffers from inefficiencies, high costs, and outdated practices, which can lead to poor patient outcomes. VALD offers a solution through advanced technologies that empower clinicians across various fields—from physical therapy to professional sports—to enhance diagnostic precision and collect real-time health data.
Innovative Tools for Better Patient Care
VALD boasts a comprehensive suite of tools tailored to assess various aspects of MSK health, such as strength, balance, and movement. These assessments were historically restricted to specialized environments like laboratories. With VALD's offerings, healthcare professionals are now able to conduct sophisticated evaluations within their own practices, ultimately improving patient care.
Insights from the CEO on Growth and Market Opportunities
Laurie Malone, CEO and co-founder of VALD, emphasized the company's impressive growth over the past decade and its position as a first mover in this largely un tapped market. The integrated products that VALD offers simplify workflows and promote higher standards of care. Malone noted that collaborating with FTV Capital will be vital for seizing the opportunities ahead, ultimately improving the lives of millions affected by MSK conditions.
The Transformative Power of VALD's Investments
Since its launch in 2015, VALD has witnessed remarkable growth, tripling its revenue since 2021 alone. With operations spanning over 30 countries and a continually growing dataset of MSK health records, VALD serves esteemed clients including leading sports organizations, top academic institutions, and military branches. This growth highlights the urgent need for effective MSK health solutions.
FTV Capital's Vision and Role in VALD's Growth
FTV Capital recognizes the increasing demand for MSK health services, particularly amid the ongoing digital transformation in the industry. Alex Mason, a partner at FTV Capital, commented on VALD's essential role in utilizing technology to support performance assessments and mobility enhancements. This partnership aims to strengthen VALD's position in the market and usher in a new era of growth.
Enhancing Leadership with Strategic Board Additions
This growth investment also brings FTV Capital partners Alex Mason and Justin Levine onto VALD's board. Their involvement is expected to provide valuable expertise and guidance as VALD charts its future course.
About VALD: Leading the Way in MSK Solutions
VALD is at the forefront of musculoskeletal assessment technologies, supplying various elite sports teams, clinics, universities, and military sectors with tools to measure human movement and assist in injury rehabilitation. Their technology platform is integrated into modern health practices, allowing for precise and efficient assessments.
About FTV Capital: Expertise in Growth Investments
Founded in 1998, FTV Capital is recognized as a significant player in the growth equity landscape, having raised over $6.2 billion. The firm invests in high-growth companies that specialize in innovative enterprise technology and financial services. FTV's commitment to transforming healthcare technology makes it the perfect partner for VALD’s ambitious expansion plans.
Frequently Asked Questions
What does VALD's new investment mean?
The investment from FTV Capital will allow VALD to grow its global team, enhance its product offerings, and advance its technology capabilities.
In which market does VALD operate?
VALD operates in the musculoskeletal (MSK) health market, focusing on innovative assessment and rehabilitation technologies to improve patient outcomes.
Who are VALD's main clients?
VALD serves major sports franchises, NCAA colleges, military branches, and healthcare systems around the world.
How has VALD's performance been since it was founded?
Since 2015, VALD has seen significant revenue growth, having tripled its income since 2021 and expanding its workforce globally.
What expertise does FTV Capital offer to VALD?
FTV Capital contributes industry insights, a strong network, and strategic guidance to help VALD effectively seize market opportunities.
